Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
The Pharmacogenomics Journal
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
2002, Volume 2, Number 1, Pages 7-10
Table of contents    Previous  Abstract  Next   Full text  PDF
News and Commentary
Metastatic medulloblastoma¾therapeutic success through molecular target identification?
M C Frühwald1 and C Plass2

1Universitätsklinikum Münster, Klinik und Poliklinik für Kinderheilkunde, Pädiatrische Hämatologie/Onkologie, Münster, Germany

2The Ohio State University, Division of Human Cancer Genetics, Columbus, Ohio, USA

Correspondence to: M C Frühwald MD, PhD, Universitätsklinikum Münster, Klinik und Poliklinik für Kinderheilkunde, Pädiatrische Hämatologie/Onkologie, Albert-Schweizer-Strabetae 33, 48149 Münster, Germany. Tel: (0251) 83 47742 Fax: (0251) 83 47828 E-mail: fruhwald@uni-muenster.de

Abstract

The Pharmacogenomics Journal (2002) 2, 7-10. DOI: 10.1038/sj/tpj/6500077

2002, Volume 2, Number 1, Pages 7-10
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 2002 Nature Publishing Group